| %Ees+ct | Percentage share of polar character of interaction according to PIEDA analysis |
| %MPE | Percent of the maximal possible effect |
| ACN | Acetonitrile |
| AUC | Area under the curve |
| CCK | Cholecystokinin |
| DALDA | [d-Arg2, Lys4]-Dermorphin-(1-4)-amide |
| DAMGO | [d-Ala2, N-Me-Phe4, Gly5-ol]-Enkephalin |
| DCC | N,N′-dicyclohexylcarbodiimide |
| DCU | N,N′-dicyclohexylourea |
| Dmt | 2′,6′-Dimethyl-l-tyrosine |
| DMF | Dimethylformamide |
| DOR | δ-Opioid receptor |
| Ect | Change-transfer contribution to PIE |
| Edisp | Dispersion contribution to PIE |
| Eex | Exchange repulsion contribution to PIE |
| Ees | Electrostatic contribution to PIE |
| ESI-MS | Electrospray-ionization mass spectrometry |
| Esolv | Gibbs solution energy |
| FA | Formic acid |
| FMO | Fragment molecular orbital |
| GAMESS | General Atomic and Molecular Electronic Structure System |
| GTPγS | Guanosine 5′-O-[γ-thio]triphosphate |
| HOSu | N-Hydroxysuccinimide |
| HPLC | High performance liquid chromatography |
| IC50 | Half-maximal inhibitory concentration |
| Ki | Inhibition constant |
| Ki-67 | Ki-67 protein |
| MD | Molecular dynamics |
| MEM | Minimal Essential Medium |
| MF | Morphine |
| MOR | μ-Opioid receptor |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NK1R | Neurokinin-1 receptor |
| OPM | Orientation of Proteins in Membrane Database |
| PIE | Pair interaction energy |
| PIEDA | Pair interaction energy decomposition analysis |
| POPC | Phosphatidylcholine |
| R | Correlation coefficient |
| RMSD | Root mean square deviation |
| RP-HPLC | Reversed-phase high performance liquid chromatography |
| SP | Substance P |
| TFA | Trifluoroacetic acid |
| TLC | Thin layer chromatography |
| TM | Transmembrane helix |
| TMG | 1,1,3,3-Tetramethylguanidine |
| VGCC | Voltage gated calcium channel |